Clinical Use of an Absorbable Coated Suture Material in Surgery (Safil)

March 25, 2008 updated by: Aesculap AG

Clinical Use of an Absorbable Coated Suture Material in Surgery (Safil) One Layer Running(A) vs. Two-Layer Suture Technique (B)

The purpose is to test a coated polyglycolic acid multifilament suture in gastrointestinal surgery as part of a controlled randomized single blinded parallel group trial. The applicability and safety of the strand material used in two suture techniques (2-layer suture technique vs. 1-layer running) are to be tested on the basis of handling characteristics, the operative time consumed for the construction of the 1st anastomosis, the average time of the hospital duration for both patient groups, and the frequency of postoperative complications after discharge, 1 month and a maximum of 3-4 months. The used suture units are counted and the length of sutures determined which will be an indirect measurement of the costs of suture material for the two techniques.

Study Overview

Study Type

Interventional

Enrollment (Actual)

210

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gyöngyös, Hungary
        • Bugat Pal Korhaz, Sebeszeti Osztaly
      • Miskolc, Hungary
        • B.-A.-Z. Megyei Korhaz, Sebeszeti Osztaly
      • Pecs, Hungary
        • Medical School of University PECS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients of both sexes, undergoing a gastrointestinal hand made one-layer running (A) or two-layer (B) anastomotic procedure where the use of synthetic absorbable surgical suture material is indicated.
  • Written consent to participate in the study

Exclusion Criteria:

  • Emergency patients that cannot be properly informed about the clinical trial and cannot give their written consent
  • Pregnancy or lactation period
  • Patients suffering from a diffuse purulent peritonitis or generalized diseases, which can have consequences for the healing of the asnastomosis (e.g. ubalanced diabetes, progressed uremia, massive hypoproteinaemia, sever jaundice, generalized intraabdominal tumor metastases, severe tumorous cachexia, severe avitaminosis, chronic liver disease.
  • Patients who are undergoing a therapeutic procedure, which can have consequences for the healing of the anastomosis (e.g. treatment with corticosteroids or cytostatics, local radiation in the operating area)
  • Laparoscopial Procedures
  • Patients who are not willing to cooperate and legally incapacitated people

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A
one layer running suture technique
Gastrointestinal Anastomosis with synthetic, absorbable, coated suture material using two different suture-techniques
Other Names:
  • SAFIL®: is a mid-term braided and coated synthetic absorbable suture made of
  • pure polyglycolic acid.
Experimental: B
two-layer suture technique
Gastrointestinal Anastomosis with synthetic, absorbable, coated suture material using two different suture-techniques
Other Names:
  • SAFIL®: is a mid-term braided and coated synthetic absorbable suture made of
  • pure polyglycolic acid.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Frequency of postoperative Complications
Time Frame: discharge, 1 month and a maximum of 3-4 months
discharge, 1 month and a maximum of 3-4 months

Secondary Outcome Measures

Outcome Measure
Time Frame
handling characteristics
Time Frame: intraoperative
intraoperative
Operation time to construct the first anastomosis
Time Frame: intraoperative
intraoperative
length of hospitalization
Time Frame: postoperative
postoperative
costs of suture material
Time Frame: intraoperative
intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: György Weber, MD, PhD, Medical School of University Pecs, Hungary

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 1998

Primary Completion (Actual)

September 1, 2001

Study Completion (Actual)

May 1, 2002

Study Registration Dates

First Submitted

March 25, 2008

First Submitted That Met QC Criteria

March 25, 2008

First Posted (Estimate)

March 28, 2008

Study Record Updates

Last Update Posted (Estimate)

March 28, 2008

Last Update Submitted That Met QC Criteria

March 25, 2008

Last Verified

March 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Diseases

Clinical Trials on Gastrointestinal Anastomosis

3
Subscribe